346 related articles for article (PubMed ID: 14645153)
21. ECH, an epoxycyclohexenone derivative that specifically inhibits Fas ligand-dependent apoptosis in CTL-mediated cytotoxicity.
Mitsui T; Miyake Y; Kakeya H; Osada H; Kataoka T
J Immunol; 2004 Mar; 172(6):3428-36. PubMed ID: 15004142
[TBL] [Abstract][Full Text] [Related]
22. Localization of Fas ligand in cytoplasmic granules of CD8+ cytotoxic T lymphocytes and natural killer cells: participation of Fas ligand in granule exocytosis model of cytotoxicity.
Kojima Y; Kawasaki-Koyanagi A; Sueyoshi N; Kanai A; Yagita H; Okumura K
Biochem Biophys Res Commun; 2002 Aug; 296(2):328-36. PubMed ID: 12163021
[TBL] [Abstract][Full Text] [Related]
23. Ca2+ signaling modulates cytolytic T lymphocyte effector functions.
Esser MT; Haverstick DM; Fuller CL; Gullo CA; Braciale VL
J Exp Med; 1998 Apr; 187(7):1057-67. PubMed ID: 9529322
[TBL] [Abstract][Full Text] [Related]
24. FD-891, a structural analogue of concanamycin A that does not affect vacuolar acidification or perforin activity, yet potently prevents cytotoxic T lymphocyte-mediated cytotoxicity through the blockage of conjugate formation.
Kataoka T; Yamada A; Bando M; Honma T; Mizoue K; Nagai K
Immunology; 2000 Jun; 100(2):170-7. PubMed ID: 10886392
[TBL] [Abstract][Full Text] [Related]
25. Treatment of melanoma with 5-fluorouracil or dacarbazine in vitro sensitizes cells to antigen-specific CTL lysis through perforin/granzyme- and Fas-mediated pathways.
Yang S; Haluska FG
J Immunol; 2004 Apr; 172(7):4599-608. PubMed ID: 15034078
[TBL] [Abstract][Full Text] [Related]
26. Protein kinase Calpha (PKCalpha) acts upstream of PKCtheta to activate IkappaB kinase and NF-kappaB in T lymphocytes.
Trushin SA; Pennington KN; Carmona EM; Asin S; Savoy DN; Billadeau DD; Paya CV
Mol Cell Biol; 2003 Oct; 23(19):7068-81. PubMed ID: 12972622
[TBL] [Abstract][Full Text] [Related]
27. Human small intestinal mucosa harbours a small population of cytolytically active CD8+ alphabeta T lymphocytes.
Melgar S; Bas A; Hammarström S; Hammarström ML
Immunology; 2002 Aug; 106(4):476-85. PubMed ID: 12153510
[TBL] [Abstract][Full Text] [Related]
28. MRL/lpr CD4- CD8- and CD8+ T cells, respectively, mediate Fas-dependent and perforin cytotoxic pathways.
Benihoud K; Bonardelle D; Bobé P; Kiger N
Eur J Immunol; 1997 Feb; 27(2):415-20. PubMed ID: 9045912
[TBL] [Abstract][Full Text] [Related]
29. Protein kinase Ctheta, a selective upstream regulator of JNK/SAPK and IL-2 promoter activation in Jurkat T cells.
Ghaffari-Tabrizi N; Bauer B; Villunger A; Baier-Bitterlich G; Altman A; Utermann G; Uberall F; Baier G
Eur J Immunol; 1999 Jan; 29(1):132-42. PubMed ID: 9933094
[TBL] [Abstract][Full Text] [Related]
30. Comparing the relative role of perforin/granzyme versus Fas/Fas ligand cytotoxic pathways in CD8+ T cell-mediated insulin-dependent diabetes mellitus.
Kreuwel HT; Morgan DJ; Krahl T; Ko A; Sarvetnick N; Sherman LA
J Immunol; 1999 Oct; 163(8):4335-41. PubMed ID: 10510373
[TBL] [Abstract][Full Text] [Related]
31. Human immunodeficiency virus reactivation by phorbol esters or T-cell receptor ligation requires both PKCalpha and PKCtheta.
Trushin SA; Bren GD; Asin S; Pennington KN; Paya CV; Badley AD
J Virol; 2005 Aug; 79(15):9821-30. PubMed ID: 16014943
[TBL] [Abstract][Full Text] [Related]
32. Fas ligand (CD95L) protects neurons against perforin-mediated T lymphocyte cytotoxicity.
Medana I; Li Z; Flügel A; Tschopp J; Wekerle H; Neumann H
J Immunol; 2001 Jul; 167(2):674-81. PubMed ID: 11441070
[TBL] [Abstract][Full Text] [Related]
33. Identification of a population of CD4+ CTL that utilizes a perforin- rather than a Fas ligand-dependent cytotoxic mechanism.
Williams NS; Engelhard VH
J Immunol; 1996 Jan; 156(1):153-9. PubMed ID: 8598456
[TBL] [Abstract][Full Text] [Related]
34. Two types of anti-TL (thymus leukemia) CTL clones with distinct target specificities: differences in cytotoxic mechanisms and accessory molecule requirements.
Tsujimura K; Takahashi T; Iwase S; Matsudaira Y; Kaneko Y; Yagita H; Obata Y
J Immunol; 1998 Jun; 160(11):5253-61. PubMed ID: 9605121
[TBL] [Abstract][Full Text] [Related]
35. Interferon-alpha (IFN-alpha) enhances cytotoxicity in healthy volunteers and chronic hepatitis C infection mainly by the perforin pathway.
Kaser A; Enrich B; Ludwiczek O; Vogel W; Tilg H
Clin Exp Immunol; 1999 Oct; 118(1):71-7. PubMed ID: 10540162
[TBL] [Abstract][Full Text] [Related]
36. Differential requirement of protein tyrosine kinase and protein kinase C in the generation of IL-2-induced LAK cell and alpha CD3-induced CD3-AK cell responses.
Ting CC; Hargrove ME; Wang J; Patel AD
Cell Immunol; 1995 Feb; 160(2):286-96. PubMed ID: 7536636
[TBL] [Abstract][Full Text] [Related]
37. Involvement of TNF-related apoptosis-inducing ligand in human CD4+ T cell-mediated cytotoxicity.
Kayagaki N; Yamaguchi N; Nakayama M; Kawasaki A; Akiba H; Okumura K; Yagita H
J Immunol; 1999 Mar; 162(5):2639-47. PubMed ID: 10072506
[TBL] [Abstract][Full Text] [Related]
38. Perforin and Fas induced by IFNgamma and TNFalpha mediate beta cell death by OT-I CTL.
McKenzie MD; Dudek NL; Mariana L; Chong MM; Trapani JA; Kay TW; Thomas HE
Int Immunol; 2006 Jun; 18(6):837-46. PubMed ID: 16574667
[TBL] [Abstract][Full Text] [Related]
39. Involvement of CD27/CD70 interactions in antigen-specific cytotoxic T-lymphocyte (CTL) activity by perforin-mediated cytotoxicity.
Yamada S; Shinozaki K; Agematsu K
Clin Exp Immunol; 2002 Dec; 130(3):424-30. PubMed ID: 12452832
[TBL] [Abstract][Full Text] [Related]
40. Concanamycin A, a powerful tool for characterization and estimation of contribution of perforin- and Fas-based lytic pathways in cell-mediated cytotoxicity.
Kataoka T; Shinohara N; Takayama H; Takaku K; Kondo S; Yonehara S; Nagai K
J Immunol; 1996 May; 156(10):3678-86. PubMed ID: 8621902
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
